3131 results for «3190»

Filter By

3131 results

Transcatheter mitral valve repair and replacement: optimal technique and procedural refinement

23 Nov 2021 – From PCR London Valves 2021

This PCR London Valves 2021 interactive learning session is designed to review the basics but also the more advanced and complex procedural steps of transcatheter mitral edge-to-edge repair, as this procedure requires a rigorous and standardized technique that can take time to learn.

Transcatheter mitral valve repair and replacement: optimal technique and procedural refinement

Mitral valve disease: diagnosis and treatment selection

23 Nov 2021 – From PCR London Valves 2021

In the first part of this PCR London Valves 2021 session, review the quantification of mitral regurgitation and learn how to better approach patients. Then, in the second part, study patient selection for specific types of procedures.

Mitral valve disease: diagnosis and treatment selection

Transcatheter mitral valve implantation

22 Nov 2021 – From PCR London Valves 2021

Shot in the simulation lab at the PCR London Valves 2021 Congress, this session enables you to see some of the anatomical specimens and devices currently used for transcatheter mitral valve replacement and witness a Tendyne implantation from start to finish using a simulated heart.

Transcatheter mitral valve implantation

Transcatheter mitral edge-to-edge repair: procedural complications and lifetime management

23 Nov 2021 – From PCR London Valves 2021

This PCR London Valves 2021 session presents different kinds of complications in mitral procedures based on clinical cases: discuss the case of an 82-year-old male patient with symptomatic severe ischemic secondary mitral regurgitation, coronary artery disease, diabetes, and chronic kidney disease, among others!

Transcatheter mitral edge-to-edge repair: procedural complications and lifetime management

Transcatheter tricuspid valve interventions: the future

23 Nov 2021 – From PCR London Valves 2021

In this PCR London Valves 2021 session, observe the case of an 84-year-old, not overweight, quite active, female patient with a past history of restrictive cardiomyopathy and permanent atrial fibrillation, who presented with worsening dyspnea and obvious clinical signs of right ventricular heart failure, and discuss the...

Transcatheter tricuspid valve interventions: the future

Coronary access following TAVI

23 Nov 2021 – From PCR London Valves 2021

Using the anatomy and imaging section and simulators, our experts dissect the case of a typical TAVI patient, an 81-year-old male, former smoker, with hypertension, dyslipidemia, and gastric ulcer, symptomatic of effort dyspnea, with marked left ventricular hypertrophy and all the parameters of severe aortic stenosis,...

Coronary access following TAVI

Tricuspid valve disease: guidelines and beyond

23 Nov 2021 – From PCR London Valves 2021

Watch this PCR London Valves 2021 session to hear about the latest European guidelines on the management of tricuspid valve disease, understand the details behind these guidelines and how they compare with those elsewhere in the world, and, most importantly, find out how Heart Teams can translate...

Tricuspid valve disease: guidelines and beyond

Commissural alignment for TAVI

23 Nov 2021 – From PCR London Valves 2021

In this PCR London Valves 2021 session shot in the simulation lab, learn tips and tricks for achieving commissural alignment, review the strategy for improving TAVR outcomes, and discuss how to get the right imaging, the right tools, and the right patients. 

Commissural alignment for TAVI

Closing Ceremony

23 Nov 2021 – From PCR London Valves 2021

Looking back on some of the key moments of the PCR London Valves 2021, it is clear that we witnessed cutting-edge procedures in all three valves, pushed the guidelines to the limits and beyond, saw the future of valve procedures with a new TAVI device implanted, live-implanted...

Closing Ceremony

The impact of the first transcatheter heart valve on the lifetime management of patients with aortic stenosis

18 May 2022 – From EUROPCR 2022

This session from EuroPCR 2022 will help you understand how the first bioprosthetic aortic valve may affect long-term outcomes of patients with aortic stenosis. Learn how to optimise their lifetime management and how to refine procedural steps during TAVI.

The impact of the first transcatheter heart valve on the lifetime management of patients with aortic stenosis

Tailored support for complex PCI and AMI with percutaneous mechanical circulatory support

17 May 2022 – From EuroPCR 2022

Watch this EuroPCR 2022 session, in which Javier Escaned, Florim Cuculi, and Norman Mangner present different cases, to learn how standard operating procedures including mechanical circulatory support improve outcomes in patients with complex coronary lesions, discuss new strategies to overcome ischemic reperfusion lesions using percutaneous mechanical circulatory support,...

Tailored support for complex PCI and AMI with percutaneous mechanical circulatory support

Is DK Crush the optimal two-stent bifurcation strategy for left main PCI?

17 May 2022 – From EuroPCR 2022

In this EuroPCR 2022 session, follow the discussion around the recorded case of a 67-year-old non-smoking male patient who presented with chest pain on exertion typical of angina for one month, and learn how to optimally treat a severely calcified long lesion, understand how imaging can...

Is DK Crush the optimal two-stent bifurcation strategy for left main PCI?

Double jeopardy: coronary disease in patients undergoing TAVI

17 May 2022 – From EuroPCR 2022

Through the presentation of real-life clinical cases, this session will allow you to discover the use of ALLEGRA for valve-in-valve TAVI, understand the management of coronary artery disease in TAVI patients, better detect when and how to protect coronary arteries during TAVI, or even learn how...

Double jeopardy: coronary disease in patients undergoing TAVI

Advancing the treatment of uncontrolled hypertension with ultrasound renal denervation

17 May 2022 – From EuroPCR 2022

This EuroPCR 2022 session, which covers the latest clinical evidence around catheter-based ultrasound renal denervation, will also enable you to appreciate the distinct features of this approach, to understand perspectives on patient selection and patient preference, and to learn how to introduce and establish interventional hypertension therapy.

Advancing the treatment of uncontrolled hypertension with ultrasound renal denervation

Towards a personalised coronary intervention with CT-guided robotic-assisted PCI

17 May 2022 – From EuroPCR 2022

This EuroPCR 2022 session aims to show how coronary CT angiography can help in pre-procedural planning and guidance of PCI to achieve the best patient outcomes. It also explores the role of robotic-assisted PCI in improving procedural accuracy, radiation safety, and ergonomics within the cathlab. Finally, it demonstrates how...

Towards a personalised coronary intervention with CT-guided robotic-assisted PCI

Start treating refractory angina patients with Reducer therapy - Practical aspects

17 May 2022 – From EuroPCR 2022

Looking at a 75-year-old male patient with HTA, diabetes, and hypothyroidism, a history of coronary artery disease treated with PCI of the RCA, and a previous coronary angiography showing preserved LVEF and in-stent restenosis of the RCA, you will learn in this EuroPCR 2022 session how...

Start treating refractory angina patients with Reducer therapy - Practical aspects

DCB and the possibility of a clean vessel

17 May 2022 – From EuroPCR 2022

This EuroPCR 2022 session aims to show, based on real-life cases, that even complex coronary disease can be treated without the need for permanent coronary stents. Learn how to prepare the vessel, deliver the therapy, and assess immediate outcomes after "DCB-alone" PCI, discuss de novo, small vessels, and...

DCB and the possibility of a clean vessel

2022: a tipping point in the treatment of mitral regurgitation patients

17 May 2022 – From EuroPCR 2022

With study outcomes and clinical cases, this EuroPCR 2022 session will enable you to discuss the anatomical considerations that define suitable candidates for treatment of mitral regurgitation with the PASCAL platform and highlight key differentiators and tips and tricks for its use.

2022: a tipping point in the treatment of mitral regurgitation patients

How to decrease operator dependence on vessel opacification during PCI? A crash course on ultra-low contrast coronary interventions

17 May 2022 – From EuroPCR 2022

Watch this EuroPCR 2022 session to become aware of the importance of relying on less contrast injections to guide PCI in complex patients, to learn what skills are required and tools available to perform ultra-low contrast coronary interventions, and to share and discuss such a recorded intervention from...

How to decrease operator dependence on vessel opacification during PCI? A crash course on ultra-low contrast coronary interventions

Sirolimus coated balloon and coronary artery disease: expanding the treatment indications

17 May 2022 – From EuroPCR 2022

Through a case presentation, as well as upcoming studies and rationale for the Food and Drug Administration, the aim of this EuroPCR 2022 session is to help you answer the following questions: how can the use of a sirolimus-coated DCB be expanded in new and challenging treatment indications? Why is...

Sirolimus coated balloon and coronary artery disease: expanding the treatment indications
Didn’t find what you were looking for?